Published in Can J Gastroenterol on March 01, 1999
Obstacles to residents' conducting research and predictors of publication. Acad Med (2001) 2.25
Mechanism of action of the calcium-sensing receptor in human antral gastrin cells. Gastroenterology (2001) 1.82
Review article: possible beneficial effects of coffee on liver disease and function. Aliment Pharmacol Ther (2007) 1.61
Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3. J Viral Hepat (2008) 1.45
Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl (2001) 1.40
Primary biliary cirrhosis and inflammatory bowel disease. Am J Gastroenterol (1993) 1.39
Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy. Gut (2006) 1.22
Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis. Am J Transplant (2006) 1.20
Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practice. Aliment Pharmacol Ther (2006) 1.07
An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C. J Viral Hepat (2008) 1.02
Obscure gastrointestinal bleeding from an ampullary tumour in a patient with a remote history of renal cell carcinoma: a diagnostic conundrum. Can J Gastroenterol (1998) 1.01
Gastrin secretion from human antral G cells in culture. Gastroenterology (1990) 1.00
Bombesin-evoked gastrin release and calcium signaling in human antral G cells in culture. Am J Physiol (1999) 0.99
Massive bleeding from multiple gastric ulcerations in a patient with lymphocytic gastritis and celiac sprue. J Clin Gastroenterol (1997) 0.98
Chinese herbal medicine, fulminant hepatitis, and liver transplantation. Am J Gastroenterol (1996) 0.95
Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance. J Hepatol (2000) 0.94
Diminutive but dangerous: a case of a polypoid rectal arteriovenous malformation. Endoscopy (2002) 0.94
The role of protein kinase C isozymes in bombesin-stimulated gastrin release from human antral gastrin cells. J Biol Chem (1999) 0.91
Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past. Transpl Infect Dis (2012) 0.90
Coexisting carcinoid tumors in familial adenomatous polyposis-associated upper intestinal adenomas. Am J Gastroenterol (1999) 0.88
Helicobacter pylori-infected human antral primary cell cultures: effect on gastrin cell function. Am J Physiol (1998) 0.87
Liver test abnormalities in multiple sclerosis: findings from placebo-treated patients. Neurology (2006) 0.87
Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine. Transplantation (1997) 0.85
Muscarinic regulation of somatostatin release from primary cultures of human antral epithelial cells. Pharmacology (1992) 0.84
Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin. Aliment Pharmacol Ther (2013) 0.84
Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: a cross-sectional analysis. Ann Oncol (1999) 0.84
Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirin. Aliment Pharmacol Ther (2008) 0.83
Liver biochemistry abnormalities in a quaternary care lipid clinic database. Ann Hepatol (2008) 0.82
Primary protein-losing enteropathy in anti-double-stranded DNA disease: the initial and sole clinical manifestation of occult systemic lupus erythematosus? J Clin Gastroenterol (2001) 0.82
Pancreatic islet isolation in rats with ductal collagenase distention, stationary digestion, and dextran separation. Transplantation (1988) 0.81
Colonic malakoplakia in a liver transplant recipient. Can J Gastroenterol (2007) 0.81
Signal transduction events involved in bombesin-stimulated gastrin release from human G cells in culture. Can J Physiol Pharmacol (1994) 0.81
Effect of cholecystokinin and secretin on somatostatin release from cultured antral cells. Gastroenterology (1993) 0.80
Impaired exercise performance after successful liver transplantation. Transplantation (2001) 0.80
Failure of ketoprofen and interferon combination therapy to improve interferon-resistant chronic hepatitis C. Can J Gastroenterol (1997) 0.80
Release of somatostatin immunoreactivity from human antral D cells in culture. Gastroenterology (1990) 0.79
L-type calcium channels regulate gastrin release from human antral G cells. Am J Physiol (1997) 0.79
Correlation between physiological assessment and outcome after liver transplantation. Am J Surg (2000) 0.79
Weight-corrected islet counts are predictive of outcome in the canine intrahepatic islet autograft model. Diabetes Res (1988) 0.78
Assessment of immunologic status of liver transplant recipients by peripheral blood mononuclear cells in response to stimulation by donor alloantigen. Ann Surg (1999) 0.78
Effect of cholinergic agonists on gastrin release from primary cultures of human antral G cells. Gastroenterology (1997) 0.77
Effects of monoclonal antibodies to somatostatin on somatostatin-induced and intestinal fat-induced inhibition of gastric acid secretion in the rat. Gastroenterology (1987) 0.77
Hyperammonemia after heart-lung transplantation. Gastroenterology (1997) 0.76
Survival after liver transplantation for hepatitis C is unchanged over two decades in Canada. Can J Gastroenterol (2008) 0.76
A simple method of canine pancreatic islet isolation and intrahepatic transplantation. J Surg Res (1989) 0.76
Donor-specific stimulation of peripheral blood mononuclear cells from recipients of orthotopic liver transplants is associated, in the absence of rejection, with type-2 cytokine production. Immunol Lett (1998) 0.76
A study of the pharmacokinetic profile of low-dose hepatitis B immune globulin in long-term liver transplant recipients for chronic hepatitis B infection. Am J Transplant (2001) 0.75
Orthotopic liver transplantation in a patient with carbamyl phosphate synthetase deficiency and cystic fibrosis. Paediatr Child Health (2003) 0.75
All that bleeds is not infliximab-refractory ulcerative colitis. Can J Gastroenterol (2009) 0.75
Crohn's disease, HIV, and AIDS. Am J Gastroenterol (1995) 0.75
Allotransplantation of culture-isolated neonatal rat islet tissue. Absence of MHC class II positive antigen-presenting cells in nonimmunogenic islets. Diabetes (1989) 0.75
Lung dysfunction and chronic liver disease. Ann Intern Med (1996) 0.75
Barriers to transplantation in adults with inborn errors of metabolism. JIMD Rep (2012) 0.75
Tomorrow's challenge in liver transplantation: diminishing the imbalance between donor organ availability and need. Gut (1998) 0.75
The use of interferon-alpha 2B in the treatment of chronic viral hepatitis in patients with preexisting idiopathic thrombocytopenic purpura. Am J Gastroenterol (1995) 0.75
Lovastatin and cholestasis. CMAJ (1993) 0.75
Hepatitis C and B-cell non-Hodgkin's lymphoma: a geographically variable association? Am J Med (2000) 0.75
Cadaver kidney transplantation with minimal delayed function: experience with perioperative strategies to enhance initial renal allograft function. Transplant Proc (1995) 0.75
Quantification of hemodynamic improvement after superficial femoral artery angioplasty by cine phase contrast MR angiography. AJR Am J Roentgenol (1999) 0.75
Primary induction with mycophenolate mofetil and corticosteroids in a liver transplant recipient with hepatorenal syndrome. Ann Pharmacother (1998) 0.75
De Novo Crohn's disease in AIDS: Crohn's disease or Crohn's "syndrome"? J Clin Gastroenterol (1998) 0.75
Comparison of two canine pancreatic islet isolation techniques. Transplant Proc (1989) 0.75
Hepatic abscesses after liver transplantation secondary to traumatic intrahepatic bile duct injuries in a cadaveric allograft donor. Transpl Int (2004) 0.75
Diabetes mellitus after liver transplantation: another extrahepatic manifestation of hepatitis C. Can J Gastroenterol (2001) 0.75
Liver enzymes as surrogate markers of hepatitis C histopathology--avoiding the liver biopsy needle? Can J Gastroenterol (2001) 0.75
Issues in organ procurement: presumed consent, bioethical type II errors, and organ registries. Ann R Coll Physicians Surg Can (1998) 0.75
Carcinoid tumors of the small intestine are uncommon, indolent, slow growing, slow metastasizing, neuroendocrine lesions. World J Surg (1994) 0.75
Canine pancreatic islet transplantation: a comparison of two isolation techniques. Eur Surg Res (1990) 0.75
Post-surgical shunt hepatopulmonary syndrome in a case of non-cirrhotic portal hypertension: lack of efficacy of shunt reversal. Eur J Gastroenterol Hepatol (1999) 0.75
Assessing virologic efficacy of combination lamivudine and low-dose hepatitis B immune globulin posttransplantation with the ultrasensitive digene hybrid capture II assay. Liver Transpl (2000) 0.75
Palliative high-dose octreotide in a case of severe AIDS-related diarrhea. Ann Pharmacother (1994) 0.75
Recurrent hepatocellular carcinoma after liver transplantation mimicking post-transplantation lymphoproliferative disorder. Australas Radiol (2005) 0.75
Peritoneal dialysis after orthotopic liver transplant surgery. Perit Dial Int (2006) 0.75
A case of recurrent pyogenic cholangitis. Dig Liver Dis (2007) 0.75